Owner Novartis AG Xenon Pharmaceuticals Inc.

Inventors Kodumuru, Vishnumurthy; Kamboj, Rajender; Fonarev, Julia; Raina, Vandna; Liu, Shifeng; Fu, Jianmin; Zhang, Zaihui; Sun, Shaoyi; Dales, Natalie; Pokrovskaia, Natalia

Agent Davies Collison Cave

Pub. Number AU-B-2007351498

PCT Pub. Number WO2008/127349

Priority 60/822,459 15.08.06 US

Filing date 13 August 2007

Wipo publication date 23 October 2008

Acceptance publication date 5 April 2012

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group